Xilong Scientific Co., Ltd.
002584.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥4 | CN¥6 | CN¥4 | CN¥6 |
| - Cash | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| + Debt | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| Enterprise Value | CN¥4 | CN¥6 | CN¥4 | CN¥6 |
| Revenue | CN¥8 | CN¥8 | CN¥6 | CN¥7 |
| % Growth | 1.6% | 24.4% | -9.6% | – |
| Gross Profit | CN¥1 | CN¥0 | CN¥0 | CN¥1 |
| % Margin | 6.9% | 6% | 7.1% | 8.2% |
| EBITDA | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 2.3% | 2% | 3.6% | 4.7% |
| Net Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 0.8% | 0.4% | 1.4% | 2.7% |
| EPS Diluted | 0.11 | 0.06 | 0.15 | 0.32 |
| % Growth | 83.3% | -60% | -53.1% | – |
| Operating Cash Flow | CN¥0 | -CN¥0 | -CN¥0 | CN¥0 |
| Capital Expenditures | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Free Cash Flow | CN¥0 | -CN¥0 | -CN¥1 | CN¥0 |